Home / Companies / News / Dhanuka Lab implements resolution plan for debt-ridden Orchid Pharma

Dhanuka Lab implements resolution plan for debt-ridden Orchid Pharma

The resolution plan will fetch the secured lenders around 32.3% recovery

Premium

The secured lenders will also receive around 4,08,164 equity shares at an issue price of Rs 10 each for part of their debt

Gireesh Babu Chennai

4 min read Last Updated : Mar 31 2020 | 8:25 PM IST

The resolution plan of Gurgaon-based Dhanuka Laboratories for the revival of Chennai-based debt-ridden Orchid Pharma Ltd has been implemented, potentially fetching secured lenders around 32.3 per cent recovery. In addition, the secured lenders will also receive around 4,08,164 equity shares at an issue price of Rs 10 each for part of their debt.

Orchid Pharma's regulatory filing on Tuesday said the paid-up equity share capital of the company has been reduced from Rs 88.96 crore to Rs Rs 40.81 crore, with cancellation of 88.56 million equity shares of Rs 10 each. A meeting of the Monitoring Committee held this week

Topics : Orchid Pharma Insolvency and Bankruptcy Code IBC NCLT

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in